BiotechTube
Home/Jarvik Heart/Robert Jarvik, MD
RJ

Robert Jarvik, MD

Chairman and Chief Executive Officer

Jarvik Heart

Therapeutic Areas

CardiovascularHeart Failure

Jarvik Heart Pipeline

DrugIndicationPhase
Jarvik 2000Severe Heart Failure (Bridge-to-Transplant & Destination Therapy)Approved
Jarvik 2015 (15mm VAD)Pediatric Severe Heart Failure (Bridge-to-Transplant)Clinical Trial

Leadership Team at Jarvik Heart

MV
Marilyn vos Savant
Chief Financial Officer
View full Jarvik Heart profile